Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006

Retina

Volumn 29, Issue 2, 2009, Pages 207-213

  Stepien, Kimberly E ^a   Eaton, Alexander M ^b   Jaffe, Glenn J ^c   Davis, Janet L ^a   Raja, Junaid ^b   Feuer, William ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Retinal Health Center   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIBIOTIC AGENT; PRESERVATIVE; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CILIARY DISK; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; ENDOPHTHALMITIS; EPIRETINAL MEMBRANE; EYE SURGERY; FEMALE; GLAUCOMA SURGERY; HEALTH CENTER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; SPRING; STERILE ENDOPHTHALMITIS; VITRECTOMY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; INJECTION; MIDDLE AGED; RISK FACTOR; SEASON; TIME; VITREOUS BODY;

AGED; AGED, 80 AND OVER; ENDOPHTHALMITIS; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INJECTIONS; MALE; MIDDLE AGED; PRESERVATIVES, PHARMACEUTICAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS; TIME FACTORS; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 63249134493     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31818eccb3     Document Type: Article

References (23)

1. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86: 247-248.
2. Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004;122:1131-1136.
3. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
4. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-772.
5. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-250.
6. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000;84:1064-1067.
7. Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 2005;40:63-68.
8. Moshfeghi DM, Kaiser PK, Bakri SJ, et al. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging 2005;36:24-29.
9. Maia M, Farah ME, Belfort RN, et al. Effects of intravitreal triamcinolone acetonide injection with and without preservative. Br J Ophthalmol 2007;91:1122-1124.
10. Magalhaes E, Nehemy P, Santos DV, Fujji G, Nehemy MB. Clinical characteristics and incidence of infectious and noninfectious endophthalmitis after intravitreous injection of triamcinolone acetonide. Arq Bras Oftalmol 2006;69:791-794.
11. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003;23:686-691.
12. Wang LC, Yang CM. Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide. Ocul Immunol Inflamm 2005;13:295-300.
13. Taban M, Singh RP, Chung JY, Lowder CY, Perez VL, Kaiser PK. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis. Am J Ophthalmol 2007;144: 50-54.
14. Scott IU, Flynn HW Jr. Reducing the risk of endophthalmitis following intravitreal injections. Retina 2007;27:10-12.
15. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-796.
16. Sharma MC, Lai WW, Shapiro MJ. Pseudohypopyon following intravitreal triamcinolone acetonide injection. Cornea 2004;23:398-399.
17. Moshfeghi AA, Scott IU, Flynn HW Jr, Puliafito CA. Pseudohy- popyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 2004;138:489-492.
18. Hernaez-Ortega MC, Soto-Pedre E. A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection. Ophthalmic Surg Lasers Imaging 2004;35:350-351.
19. Garcia-Arumi J, Boixadera A, Giralt J, et al. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br J Ophthalmol 2005;89: 1112-1114.
20. Lorenzo Carrero J, Gonzalez Barcia M, Perez Flores I. Sterile endophthalmitis after benzyl alcohol filtered triamcinolone acetonide injection. Arch Ophthalmol 2008;126:142-143.
21. LUCENTIS™ (ranibizumab injection) Prescribing Information. Availableat:http://www.gene.com/gene/products/information/tgr/ lucentis/insert.jsp. Accessed September 1, 2006.
22. Holland SP, Mathias RG, Morck DW, Chiu J, Slade SG. Diffuse lamellar keratitis related to endotoxins released from sterilizer reservoir biofilms. Ophthalmology 2000;107:1227- 1233; discussion 1233-1234.
23. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-1282.